Published in Cancer Weekly, March 30th, 2010
"To decide appropriate target agent, evaluating the status of target molecule is mandatory. Anti-angiogenic therapy is widely used as a clinical strategy for cancer treatment such as colorectal cancer, lung cancer. In case of anti-angiogenic treatment, angiogenesis imaging could select the patients who respond to anti-angiogenic treatment. There are several methods to evaluate angiogenesis. Angiogenesis could be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.